These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2396591)

  • 41. [Latency of the L forms of beta-hemolytic streptococci in the tissues of experimentally infected animals].
    Kagan GIa; Vul'fovich IuV; Chumachenko NV; Koptelova EI
    Vestn Akad Med Nauk SSSR; 1973; 28(2):71-5. PubMed ID: 4204260
    [No Abstract]   [Full Text] [Related]  

  • 42. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
    Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
    Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serum secretory IgA level in patients with Behçet's disease].
    Nio T; Sunakawa M; Ohshio G; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1988 Nov; 92(11):1740-3. PubMed ID: 3228023
    [No Abstract]   [Full Text] [Related]  

  • 46. Lymphocyte gamma-glutamyl transferase activity in Behçet's disease.
    Pabuçcuoğlu A; Karan A; Andaç K; Yağci A
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):121-5. PubMed ID: 2575892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
    Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
    J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease.
    Niwa Y; Mizushima Y
    Clin Exp Immunol; 1990 Mar; 79(3):353-60. PubMed ID: 2180598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating immune complexes in Behçet's disease.
    Inoue T; Oniki S; Kajiyama K; Jimi S
    Jpn J Ophthalmol; 1983; 27(1):35-9. PubMed ID: 6602236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complement titer in patient with Behçet's disease].
    Kogure M; Shimada K; Hara H
    Nippon Ganka Gakkai Zasshi; 1971; 75(5):1260-8. PubMed ID: 5105029
    [No Abstract]   [Full Text] [Related]  

  • 51. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
    Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
    Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte abnormalities in Behçet's syndrome.
    Denman AM; Fialkow PJ; Pelton BK; Salo AC; Appleford DJ; Gilchrist C
    Clin Exp Immunol; 1980 Oct; 42(1):175-85. PubMed ID: 6161726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evidence in tissue culture of group A. L form streptococcal substances reacting with anti-L form immune serum].
    Goldstein I; Magis C; Schmitt-Slomska J
    C R Acad Hebd Seances Acad Sci D; 1968 Dec; 267(26):2387-90. PubMed ID: 4975957
    [No Abstract]   [Full Text] [Related]  

  • 55. Serologic studies of staphylococcal and streptococcal L-forms.
    Dannis DC; Sharp JT; Marston JH
    Ann N Y Acad Sci; 1970 Oct; 174(2):922-7. PubMed ID: 4993534
    [No Abstract]   [Full Text] [Related]  

  • 56. [Free and bound antigen of Streptococcus group A L forms and the circulating immune complex level of erysipelas patients].
    Gorina LG; Kagan GIa; Gavrilova GA; Goncharova SA; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):106-9. PubMed ID: 6195846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunopathogenesis and prevention of uveitis with the Behçet's disease-specific peptide linked to cholera toxin B.
    Lehner T; Stanford MR; Phipps PA; Sun JB; Xiao BG; Holmgren J; Shinnick T; Hasan A; Mizushima Y
    Adv Exp Med Biol; 2003; 528():173-80. PubMed ID: 12918685
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibodies against Yersinia, Campylobacter, Salmonella, and Chlamydia in patients with Behçet's disease.
    Toivanen A; Lahesmaa-Rantala R; Meurman O; Sappinen O; Kosunen T; Yazici H; Yurdakul S; Ozbakir F; Müftüoglu A
    Arthritis Rheum; 1987 Nov; 30(11):1315-7. PubMed ID: 3689469
    [No Abstract]   [Full Text] [Related]  

  • 59. Dynamics of the immunologic response of Macaca rhesus infected with L-forms of hemolytic Streptococcus.
    Chumachenko NV; Kagan GY; Shmitt-Slomska ZI; Koptelova EI; Rakovskaya IV; Vul'fovich YV; Goncharova SA
    Bull Exp Biol Med; 1974 Sep; 77(3):308-10. PubMed ID: 4412874
    [No Abstract]   [Full Text] [Related]  

  • 60. Lymphocyte transformation using streptococcal antigens and serum antistreptokinase titers in Behçet disease.
    Yamada M; Fujimoto F; Uragami K; Yanase K
    J Dermatol; 1975 Dec; 2(4):179-85. PubMed ID: 770543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.